Kevin Conroy

Overview

Kevin Conroy is an American entrepreneur and investor specializing in early-stage technology companies. He is the founder and CEO of ConroyCo Ventures, a firm that provides consulting and advisory services to accelerate the growth of early-stage and high-growth companies. ConroyCo Ventures focuses on sectors such as technology, media, entertainment, healthcare, and biotechnology, with a particular emphasis on venture capital investments. The firm operates primarily in the United States, targeting seed to growth-stage companies across various industries. Prior to founding ConroyCo Ventures, Conroy held several senior positions in prominent media and technology companies. He served as President and Chief Executive Officer of Exact Sciences Corporation, a biotechnology firm specializing in cancer diagnostics. Under his leadership, Exact Sciences developed and commercialized Cologuard®, a non-invasive colorectal cancer screening test. Conroy also held executive roles at Univision Communications, Inc., where he was Chief Strategy and Data Officer, and at Metro-Goldwyn-Mayer (MGM), where he was President of Digital and New Platforms. His career also includes significant contributions to AOL and BMG Entertainment. Conroy's investment philosophy centers on identifying and nurturing innovative companies with high growth potential. He leverages his extensive experience in media, technology, and healthcare to provide strategic guidance and resources to portfolio companies. His approach combines operational expertise with a deep understanding of market dynamics, aiming to create value and drive sustainable growth in the companies he invests in.

Investment Focus

• Innovative technology solutions
• Scalable business models
• Experienced management teams
• Clear market differentiation
• Strong growth potential

Portfolio Companies